...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

New In-situ Hydrolysis SPE Plates from Biotage

| Print |
Monday, 18 September 2017 10:15 (UTC + 2)

biotage logo

Uppsala, Sweden, September 18, 2017 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction plates with an integral Hydrolysis capability that enable chemists to perform sample hydrolysis within the extraction plate; saving time and reducing sample transfer issues.

EVOLUTE® HYDRO Solid Phase Extraction plates gives customers the ability to perform sample (typically urine) hydrolysis within the wells of the extraction plate, followed directly by sample clean up using solid phase extraction, without the need for sample transfer. The Hydro frit technology used by the plates reliably “holds up” both sample and enzyme during incubation at elevated temperatures.  This reduces clogging during subsequent clean up steps, leading to robust and streamlined sample preparation. Sample clean-up is performed in the same plate, without the need to transfer samples, saving time and reducing risky sample handling steps.

The plates are packed with high quality 30 µm EVOLUTE® media, with CX (mixed mode strong cation exchange) and ABN (wettable/non-polar) phases available at launch. EVOLUTE® HYDRO can be processed using 96-well compatible positive pressure manifolds (e.g. Biotage® Pressure+ 96), vacuum manifolds (e.g. Biotage® VacMaster™ 96) and automated liquid handling systems (e.g. Biotage® Extrahera™).

“By combining our unique Hydro frit technology with our wettable EVOLUTE® sorbents, the new SPE plates allow the hydrolyzed sample to be loaded directly onto the SPE bed for clean-up.  The conditioning and equilibration steps are eliminated, saving time and reducing costs.” said Dr. Claire Desbrow, Global Product Manager, Analytical Chemistry, Biotage.

For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 3 5627 3123, other areas please call +46 18 56 57 10.


About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in South Korea, China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 308 employees, with sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.


Contact

James Churchill
Marketing Communications
Biotage GB Ltd.
Distribution Way
Dyffryn Business Park
Ystrad Mynach
Hengoed, Wales 
CF82 7TS  United Kingdom
Tel: +44 (0)1443 811 849 
Mobile: +44(0)7875484778
This e-mail address is being protected from spambots. You need JavaScript enabled to view it